[go: up one dir, main page]

DE69106777D1 - Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination. - Google Patents

Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.

Info

Publication number
DE69106777D1
DE69106777D1 DE69106777T DE69106777T DE69106777D1 DE 69106777 D1 DE69106777 D1 DE 69106777D1 DE 69106777 T DE69106777 T DE 69106777T DE 69106777 T DE69106777 T DE 69106777T DE 69106777 D1 DE69106777 D1 DE 69106777D1
Authority
DE
Germany
Prior art keywords
treatment
synergistic combination
ophthalmic
intraocular pressure
oculo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106777T
Other languages
English (en)
Other versions
DE69106777T2 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15092428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69106777(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DE69106777D1 publication Critical patent/DE69106777D1/de
Publication of DE69106777T2 publication Critical patent/DE69106777T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69106777T 1990-05-22 1991-05-21 Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination. Expired - Fee Related DE69106777T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291290 1990-05-22

Publications (2)

Publication Number Publication Date
DE69106777D1 true DE69106777D1 (de) 1995-03-02
DE69106777T2 DE69106777T2 (de) 1995-05-18

Family

ID=15092428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106777T Expired - Fee Related DE69106777T2 (de) 1990-05-22 1991-05-21 Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.

Country Status (9)

Country Link
US (1) US5397797A (de)
EP (1) EP0458589B1 (de)
JP (1) JP2511587B2 (de)
KR (1) KR960010437B1 (de)
AT (1) ATE117208T1 (de)
CA (1) CA2042934C (de)
DE (1) DE69106777T2 (de)
DK (1) DK0458589T3 (de)
ES (1) ES2069823T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
EP0664707B1 (de) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure
EP0949688A1 (de) * 1998-03-31 1999-10-13 Phototronics Solartechnik GmbH Dünnschichtsolarzelle, Verfahren zu deren Herstellung sowie Vorrichtung zur Durchführung des Verfahrens
MXPA03005922A (es) * 2000-12-29 2004-05-04 Alteon Inc Metodo para tratar glaucoma ib.
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
US20040007269A1 (en) * 2002-07-12 2004-01-15 Larsen Todd W. Inline pressure reducing regulator
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US7757710B2 (en) * 2006-06-19 2010-07-20 Tescom Corporation High-pressure regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
DE3876050T2 (de) * 1987-09-18 1993-03-25 Ueno Seiyaku Oyo Kenkyujo Kk Okulare hypotensivagenzien.
DE68928551T2 (de) * 1988-10-01 1998-04-23 Ueno Seiyaku Oyo Kenkyujo Kk Oculare hypotensive Mittel

Also Published As

Publication number Publication date
US5397797A (en) 1995-03-14
DK0458589T3 (da) 1995-04-03
ES2069823T3 (es) 1995-05-16
ATE117208T1 (de) 1995-02-15
EP0458589A1 (de) 1991-11-27
EP0458589B1 (de) 1995-01-18
CA2042934A1 (en) 1991-11-23
DE69106777T2 (de) 1995-05-18
JPH04253912A (ja) 1992-09-09
JP2511587B2 (ja) 1996-06-26
CA2042934C (en) 2002-04-23
KR960010437B1 (ko) 1996-08-01
KR910019623A (ko) 1991-12-19

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69317537D1 (de) Antiallergische Zusammensetzung zur ophthalmischen oder nasalen Anwendung
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE69123892D1 (de) Behandlung von Katarakt mit prostacyclinverbindungen
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee